% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Eckardt:212453,
author = {J.-N. Eckardt and S. Stasik and C. Röllig and T. Sauer$^*$
and S. Scholl and A. Hochhaus and M. Crysandt and T. H.
Brümmendorf and R. Naumann and B. Steffen and V. Kunzmann
and H. Einsele and M. Schaich and A. Burchert and A.
Neubauer and K. Schäfer-Eckart and C. Schliemann and S. W.
Krause and R. Herbst and M. Hänel and M. Hanoun and U.
Kaiser and M. Kaufmann and Z. Rácil and J. Mayer and T.
Cerqueira and F. Kroschinsky and W. E. Berdel and H. Serve
and C. Müller-Tidow$^*$ and U. Platzbecker and C. D. Baldus
and J. Schetelig and T. Siepmann and M. Bornhäuser$^*$ and
J. M. Middeke and C. Thiede},
title = {{A}lterations of cohesin complex genes in acute myeloid
leukemia: differential co-mutations, clinical presentation
and impact on outcome.},
journal = {Blood cancer journal},
volume = {13},
number = {1},
issn = {2044-5385},
address = {London [u.a.]},
publisher = {Nature Publishing Group},
reportid = {DKFZ-2023-00170},
pages = {18},
year = {2023},
abstract = {Functional perturbations of the cohesin complex with
subsequent changes in chromatin structure and replication
are reported in a multitude of cancers including acute
myeloid leukemia (AML). Mutations of its STAG2 subunit may
predict unfavorable risk as recognized by the 2022 European
Leukemia Net recommendations, but the underlying evidence is
limited by small sample sizes and conflicting observations
regarding clinical outcomes, as well as scarce information
on other cohesion complex subunits. We retrospectively
analyzed data from a multi-center cohort of 1615 intensively
treated AML patients and identified distinct co-mutational
patters for mutations of STAG2, which were associated with
normal karyotypes (NK) and concomitant mutations in IDH2,
RUNX1, BCOR, ASXL1, and SRSF2. Mutated RAD21 was associated
with NK, mutated EZH2, KRAS, CBL, and NPM1. Patients
harboring mutated STAG2 were older and presented with
decreased white blood cell, bone marrow and peripheral blood
blast counts. Overall, neither mutated STAG2, RAD21, SMC1A
nor SMC3 displayed any significant, independent effect on
clinical outcomes defined as complete remission, event-free,
relapse-free or overall survival. However, we found almost
complete mutual exclusivity of genetic alterations of
individual cohesin subunits. This mutual exclusivity may be
the basis for therapeutic strategies via synthetic lethality
in cohesin mutated AML.},
cin = {A360 / DD01 / A350},
ddc = {610},
cid = {I:(DE-He78)A360-20160331 / I:(DE-He78)DD01-20160331 /
I:(DE-He78)A350-20160331},
pnm = {311 - Zellbiologie und Tumorbiologie (POF4-311)},
pid = {G:(DE-HGF)POF4-311},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36693840},
doi = {10.1038/s41408-023-00790-1},
url = {https://inrepo02.dkfz.de/record/212453},
}